At the age of six, Joud has had a tough start to life. Small and delicate, he underwent treatment for leukaemia in Erbil, in Iraq’s northwest, before moving to the Syrian capital of Damascus to continue it.
His uncle Farid, an academic, admits that this has not been cheap. The monthly medication alone has cost $1,600, he explains.
This does not include tests, Joud’s hospitalisation costs, doctors’ fees, or the specific blood and cell tests only available in Germany, at a cost of $2,000.
The treatment plan changed recently. The family now pays $1,000 every month. It is better, but still not cheap. “In nearly two years, we’ve spent $100,000,” says Farid.
“In our family, we have ten cancer cases, including breast and colon cancer. Sadly, we lost two members to lung cancer.”
Their story is not unique. Alas, it is the norm.
From the city of Tabqa in northeast Syria, Maria Al-Khamri tells of her daughter Ilaaf’s struggle with osteosarcoma, a type of bone cancer. At the age of 23, Ilaaf has had a seven-year ordeal, including having her foot amputated.
Misdiagnosed by orthopaedic doctors and neurologists, with a botched biopsy to boot, “medical errors” led to her tumour worsening, says Maria from Damascus.
“The disease is now terminal. It has spread throughout her body. We sold our land, jewellery, and furniture, but still, she worsened. The oncology centre in Raqqa lacks skilled doctors. It can’t offer the necessary radiological services.”
She says the region is “rich in resources but lacks medical professionals”, adding that those still there “have received no assistance”.
Cancer in the air
In 2013, the World Health Organisation (WHO) classified outdoor air pollutants as carcinogens, recognising them as significant factors in cancer-related deaths.
The WHO supported this classification with evidence of the association between exposure to air pollution and the prevalence of lung cancer.